Loading...
Reach Banner
Keywords
Last name
Institution

Connection

Khosrow Adeli to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Khosrow Adeli has written about Dose-Response Relationship, Drug.

 
Connection Strength
 
 
 
0.589
 
  1. Basciano H, Miller AE, Naples M, Baker C, Kohen R, Xu E, Su Q, Allister EM, Wheeler MB, Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am J Physiol Endocrinol Metab. 2009 Aug; 297(2):E462-73.
    View in: PubMed
    Score: 0.091
  2. Tsai J, Qiu W, Kohen-Avramoglu R, Adeli K. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly. Arterioscler Thromb Vasc Biol. 2007 Jan; 27(1):211-8.
    View in: PubMed
    Score: 0.076
  3. Qiu W, Avramoglu RK, Rutledge AC, Tsai J, Adeli K. Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins. J Lipid Res. 2006 Aug; 47(8):1749-61.
    View in: PubMed
    Score: 0.074
  4. Chong T, Naples M, Federico L, Taylor D, Smith GJ, Cheung RC, Adeli K. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia. Atherosclerosis. 2006 Mar; 185(1):21-31.
    View in: PubMed
    Score: 0.070
  5. Bonn V, Cheung RC, Chen B, Taghibiglou C, Van Iderstine SC, Adeli K. Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes. Atherosclerosis. 2002 Jul; 163(1):59-68.
    View in: PubMed
    Score: 0.056
  6. Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le-Tien H, Fantus IG, Lewis GF, Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem. 2002 Jan 04; 277(1):793-803.
    View in: PubMed
    Score: 0.054
  7. Theriault A, Wang Q, Gapor A, Adeli K. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler Thromb Vasc Biol. 1999 Mar; 19(3):704-12.
    View in: PubMed
    Score: 0.045
  8. McNamara PJ, Engelberts D, Finelli M, Adeli K, Kavanagh BP. Vasopressin improves survival compared with epinephrine in a neonatal piglet model of asphyxial cardiac arrest. Pediatr Res. 2014 Jun; 75(6):738-48.
    View in: PubMed
    Score: 0.032
  9. Mokhtari RB, Kumar S, Islam SS, Yazdanpanah M, Adeli K, Cutz E, Yeger H. Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines. BMC Cancer. 2013 Aug 08; 13:378.
    View in: PubMed
    Score: 0.030
  10. Dong B, Wu M, Li H, Kraemer FB, Adeli K, Seidah NG, Park SW, Liu J. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. J Lipid Res. 2010 Jun; 51(6):1486-95.
    View in: PubMed
    Score: 0.024
  11. Engelhardt T, McCheyne AJ, Morton N, Karsli C, Luginbuehl I, Adeli K, Walsh W, Bissonnette B. Clinical adaptation of a pharmacokinetic model of Propofol plasma concentrations in children. Paediatr Anaesth. 2008 Mar; 18(3):235-9.
    View in: PubMed
    Score: 0.021
  12. Casaschi A, Maiyoh GK, Rubio BK, Li RW, Adeli K, Theriault AG. The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J Nutr. 2004 Jun; 134(6):1340-6.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.